Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Sept 2026 for 10x Genomics, Inc., €1.1M. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Stuelpnagel John R: trading record in brief
Stuelpnagel John R discloses dealings in 2 companies, chiefly 10x Genomics, Inc. and ICONIQ Access LXIX, L.P. We count 3 filings; the first trade dates from 11 August 2026 and the latest from 3 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 3 September 2026, the filings show a transaction worth €1.1M in 10x Genomics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stuelpnagel John R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
20,000 shares@ US$61.7523Class A commonSEC144:0001957799-26-000170
20,000 shares@ US$57.75160.017% mcap21.7% of flowClass A commonSEC144:0001957799-26-000152
20,000 shares@ US$57.7516100.0% of flowClass A commonSEC144:0001957799-26-000151
3 of 3 declarations
